Rhian M. Touyz

Research interests

Publications

• 2024 ESC Guidelines for the management of elevated blood pressure and hypertension

  European Heart Journal · 2024 · https://doi.org/10.1093/eurheartj/ehae178

• 2023 ESC Guidelines for the management of cardiomyopathies

  European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad194

• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

  European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad192

• 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac237

• 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac262

• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

  European Heart Journal · 2022 · 10.1093/eurheartj/ehac244

• 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

  European Heart Journal · 2022 · 10.1093/eurheartj/ehac270

• 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

  EP Europace · 2021 · 10.1093/europace/euab232

• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab484

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

• 2020 ESC Guidelines for the management of adult congenital heart disease

  European Heart Journal · 2020 · 10.1093/eurheartj/ehaa554

• COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

  Cardiovascular Research · 2020 · 10.1093/cvr/cvaa106

• Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

  Circulation Research · 2020 · 10.1161/circresaha.120.317134

• May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz300

• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

  Atherosclerosis · 2019 · https://doi.org/10.1016/j.atherosclerosis.2019.08.014

• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

  European Heart Journal · 2019 · https://doi.org/10.1093/eurheartj/ehz486

• Vascular dysfunction—The disregarded partner of Alzheimer's disease

  Alzheimer s & Dementia · 2019 · 10.1016/j.jalz.2018.07.222

• Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina

  Journal of the American College of Cardiology · 2018 · 10.1016/j.jacc.2018.09.006

• Vascular smooth muscle contraction in hypertension

  Cardiovascular Research · 2018 · 10.1093/cvr/cvy023

• Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms

  Canadian Journal of Cardiology · 2017 · 10.1016/j.cjca.2017.12.005

• Oxidative Stress, Inflammation, and Vascular Aging in Hypertension

  Hypertension · 2017 · 10.1161/hypertensionaha.117.07802

• Clinical Practice Guidelines for the Management of Hypertension in the Community

  Journal of Clinical Hypertension · 2013 · 10.1111/jch.12237

• NADPH Oxidases, Reactive Oxygen Species, and Hypertension

  Diabetes Care · 2008 · 10.2337/dc08-s247

• Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension

  Hypertension · 2004 · 10.1161/01.hyp.0000138070.47616.9d

• Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells

  Pharmacological Reviews · 2000 · 10.1016/s0031-6997(24)01471-6

Current projects

No projects listed.